Open Access(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
Author(s) -
Siraya Jaijakul,
José A. Vázquez,
R. N. Swanson,
Luis OstroskyZeichner
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis456
Subject(s) - invasive candidiasis , biomarker , glucan , medicine , oncology , biology , dermatology , antifungal , fluconazole , biochemistry
(1,3)-β-D-glucan (BG) is a biomarker for invasive candidiasis (IC). The usefulness of BG level as a prognostic marker of treatment outcome is not well characterized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom